-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Zenas BioPharma, Inc. quarterly Earnings Per Share, Basic history and growth rate from Q3 2023 to Q3 2024.
- Zenas BioPharma, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -5.02 USD/shares, a 307% decline year-over-year.
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)